The Road Ahead for the Percutaneous Mechanical Circulatory Support Devices Market: Key Growth Trends and Opportunities to Watch
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What CAGR is Anticipated for the Percutaneous Mechanical Circulatory Support Devices Market During the Forecast Period, and Why?
The market for percutaneous mechanical circulatory support devices has seen a significant surge in recent times. Its size is projected to expand from $2.26 billion in 2024 to $2.48 billion in 2025, representing a compound annual growth rate (CAGR) of 10.0%. This accelerated growth during the historic period can be traced back to factors like a surge in cardiovascular disease cases, a rising elderly population, a jump in heart attack incidences, improved awareness and screening initiatives, and heightened demand for heart pump equipment.
It is anticipated that the market for percutaneous mechanical circulatory support devices will experience significant growth in the coming years, rising to a worth of $3.60 billion by 2029 with a compound annual growth rate of 9.7%. This anticipated growth during the forecast period can be attributed to a rising demand for long-term mechanical circulatory support, a growing healthcare budget, an increasing diabetic and obese demographic, a higher demand for heart transplants, and a growing acceptance of percutaneous procedures. Key trends expected during the forecast period include advancements in pump technology, developments in medical technology, cardiac support technologies, non-invasive medical technologies, and progression in biocompatible materials.
How Are the key drivers Contributing to the Expansion of the Percutaneous Mechanical Circulatory Support Devices Market?
The proliferation of cardiovascular diseases is anticipated to fuel the expansion of the percutaneous mechanical circulatory support devices market. These diseases refer to a collection of disorders that affect the heart and blood vessels and include conditions like coronary artery disease, heart attacks, heart failure, stroke, and hypertension. The growth of cardiovascular diseases can be linked to various factors such as escalating aged population, unhealthy lifestyle patterns, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices play a crucial role in these diseases, aiding in enhancing cardiac function, reducing heart stress, and aiding recovery in severe cardiac conditions. For instance, the Australian Institute of Health and Welfare, a government agency based in Australia, reported certified physician deaths caused by coronary heart disease (CHD) escalating to 14,100 in 2021 and further shot up to 14,900 in 2022. Therefore, the surging incidence of cardiovascular diseases is stimulating the growth of the percutaneous mechanical circulatory support (MCS) devices market.
Get Your Free Sample of the Global Percutaneous Mechanical Circulatory Support Devices Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
Which Companies Are Poised to Shape the Future of the Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are:
• Abbott Laboratories_x000D_
• Medtronic Plc_x000D_
• Getinge AB_x000D_
• Teleflex Incorporated_x000D_
• Biotronik_x000D_
What Are the Latest Innovations and Trends Influencing the Percutaneous Mechanical Circulatory Support Devices Market?
Key enterprises in the percutaneous mechanical circulatory support devices market are focussed on developing groundbreaking technological solutions like intra-aortic axial-flow devices, to augment patient wellbeing and mitigate surgical risks. An intra-aortic axial-flow device is a specific type of percutaneous mechanical circulatory support device formulated to aid cardiovascular performance by increasing the blood flow from the left ventricle to the aorta. For example, Procyrion, Inc., a medical device firm based in the USA, proclaimed the first successful deployment of its Aortix pump in a human body in February 2023. This inventive gadget is designed to avert acute kidney injury in patients undergoing heart surgery. Deployed through a catheter in the descending thoracic aorta, it improves renal perfusion while lessening the cardiac load during operations. The device achieves this by improving both the renal and systemic perfusion while concurrently take off pressure on the heart, making it highly beneficial for patients with limited left ventricular function and kidney problems. Capable of pumping a maximum of five liters per minute, the Aortix pump is designed for temporary use during operations like percutaneous coronary interventions.
Get Instant Access to the Global Percutaneous Mechanical Circulatory Support Devices Market Report with Swift Delivery!
Which Industry Segments Are Leading the Development and Expansion of the Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
What Regions Are Contributing Significantly to the Growth of the Percutaneous Mechanical Circulatory Support Devices Market?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Scope and Reach of the Percutaneous Mechanical Circulatory Support Devices Market Defined?
Percutaneous mechanical circulatory support (pMCS) devices are minimally invasive systems used to temporarily assist or completely replace the pumping function of the heart. These devices are inserted through a catheter into blood vessels, typically via the femoral artery, and positioned in the heart to provide mechanical support during acute heart failure, cardiogenic shock, or high-risk cardiac interventions.
Browse Through More Similar Reports By The Business Research Company:
Mechanical Power Transmission Equipment Global Market Report 2025
Mechanical Ventilator Global Market Report 2025
https://thebusinessresearchcompany.com/report/mechanical-ventilator-global-market-report
Microelectromechanical Systems Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/microelectromechanical-systems-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
